uploads///Sutent

How Pfizer’s Sutent and Xalkori Have Performed

By

Dec. 24 2018, Updated 3:35 p.m. ET

Sutent revenue

In the first nine months of this year, Pfizer’s (PFE) Sutent sales fell 2% YoY (year-over-year) to $785.0 million from $805.0 million. Sutent operations declined ~5% YoY. US Sutent sales fell ~6% YoY to $262.0 million from $277.0 million, and international Sutent sales fell 1% YoY to $524.0 million from $527.0 million.

In the third quarter, Sutent revenue fell ~10% YoY to $248.0 million. US and international Sutent revenue fell ~7% and ~11% YoY to $80.0 million and $168.0 million, respectively.

Article continues below advertisement

Xalkori revenue

In the first nine months of this year, Pfizer’s Xalkori sales fell ~6% to $417.0 million from $442.0 million, and Xalkori operations declined ~9% YoY. US and international Xalkori revenue fell ~31% and ~10% YoY, respectively, to $118.0 million and $299.0 million.

In the third quarter, Xalkori revenue fell ~13% YoY to $127.0 million. US and international Xalkori sales fell ~31% and ~4% YoY to $34.0 million and $93.0 million, respectively. Xalkori competes with Roche’s (RHHBY) Alecensa, Novartis’s (NVS) Zykadia, and Takeda Pharmaceutical’s (TKPYY) Alunbrig. In the first nine months of this year, Roche’s Alecensa revenue grew 79% YoY to 437.0 million Swiss francs.

Advertisement

More From Market Realist

  • Michelob Ultra beer
    Company & Industry Overviews
    AB InBev Is the Top Beer Brand Worldwide—Is It a Monopoly?
  • Businesswoman looking out a window
    Company & Industry Overviews
    Shifting Focus: Three Women Investing Funds in 2021
  • Aol logo on office building,
    Company & Industry Overviews
    What We Know About Apollo Global Management, New Owners of AOL and Yahoo
  • Chick-fil-A sign
    Company & Industry Overviews
    Why It Only Costs $10K to Own a Chick-fil-A Location
  • CONNECT with Market Realist
  • Link to Facebook
  • Link to Twitter
  • Link to Instagram
  • Link to Email Subscribe
Market Realist Logo
Do Not Sell My Personal Information

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.